Nanjing Vishee Medical Technology Co (SHSE:688580) Cash, Cash Equivalents, Marketable Securities : ¥1,114.7 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Cash, Cash Equivalents, Marketable Securities?

Nanjing Vishee Medical Technology Co's quarterly cash, cash equivalents, marketable securities increased from Sep. 2023 (¥1,133.18 Mil) to Dec. 2023 (¥1,154.99 Mil) but then stayed the same from Dec. 2023 (¥1,154.99 Mil) to Mar. 2024 (¥1,114.69 Mil).

Nanjing Vishee Medical Technology Co's annual cash, cash equivalents, marketable securities declined from Dec. 2021 (¥1,365.98 Mil) to Dec. 2022 (¥1,248.13 Mil) and declined from Dec. 2022 (¥1,248.13 Mil) to Dec. 2023 (¥1,154.99 Mil).

Nanjing Vishee Medical Technology Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Cash, Cash Equivalents, Marketable Securities Chart

Nanjing Vishee Medical Technology Co Annual Data

Trend

Dec13

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

Get a 7-Day Free Trial

244.35

1,366.46

1,365.98

1,248.13

1,154.99

Nanjing Vishee Medical Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															1,241.74	1,145.73	1,133.18	1,154.99	1,114.69

Nanjing Vishee Medical Technology Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Nanjing Vishee Medical Technology Co (SHSE:688580) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Nanjing Vishee Medical Technology Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012

Website

http://www.vishee.com

Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.

Executives

Huang He	Senior management, core technical personnel
Chou Kai	Senior management, core technical personnel
Zhong Yi Qun	senior management
Chen Li Li	Directors, senior managers
Zhang Hui	senior management
Gao Fei	Core technical personnel
Lian Qing Ming	Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines